SCHEDULE 14A

                                 (Rule 14a-101)

                     INFORMATION REQUIRED IN PROXY STATEMENT

                            SCHEDULE 14A INFORMATION

                Proxy Statement Pursuant to Section 14(a) of the
               Securities Exchange Act of 1934 (Amendment No.   )

Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]

Check the appropriate box:

[X]  Preliminary Proxy Statement          [_]  Soliciting Material Under Rule
[_]  Confidential, For Use of the              14a-12
     Commission Only (as permitted
     by Rule 14a-6(e)(2))
[_]  Definitive Proxy Statement
[_]  Definitive Additional Materials



                              TAG-IT PACIFIC, INC.
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)



- --------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)


Payment of Filing Fee (Check the appropriate box):

[X]  No fee required.
[_]  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

1)   Title of each class of securities to which transaction applies:

________________________________________________________________________________
2)   Aggregate number of securities to which transaction applies:

________________________________________________________________________________

3)   Per unit price or other underlying value of transaction  computed  pursuant
     to Exchange  Act Rule 0-11 (set forth the amount on which the filing fee is
     calculated and state how it was determined):

________________________________________________________________________________
4)   Proposed maximum aggregate value of transaction:

________________________________________________________________________________
5)   Total fee paid:

________________________________________________________________________________
[_]  Fee paid previously with preliminary materials:

________________________________________________________________________________
[_]  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the filing for which the  offsetting  fee was paid
     previously.  Identify the previous filing by registration statement number,
     or the form or schedule and the date of its filing.

     1)   Amount previously paid:

________________________________________________________________________________
     2)   Form, Schedule or Registration Statement No.:

________________________________________________________________________________
     3)   Filing Party:

________________________________________________________________________________
     4)   Date Filed:

________________________________________________________________________________





                              TAG-IT PACIFIC, INC.
              -----------------------------------------------------

                    NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
              -----------------------------------------------------


TIME............................   10:00 a.m. Pacific Time on February 11, 2004.

PLACE...........................   Tag-It Pacific, Inc.'s Corporate Headquarters
                                   at  21900  Burbank   Boulevard,   Suite  270,
                                   Woodland Hills, California 91367.

ITEMS OF BUSINESS...............   (1)  To approve  the  issuance  of  5,728,180
                                        shares of  common  stock  issuable  upon
                                        conversion of the outstanding  shares of
                                        Series D Preferred Stock.
                                   (2)  To transact  such other  business as may
                                        properly come before the Special Meeting
                                        and any adjournment or postponement.

RECORD DATE.....................   You can vote if you were a stockholder of the
                                   Company at the close of  business  on January
                                   5, 2004.

PROXY VOTING....................   All  stockholders  are  cordially  invited to
                                   attend   the   Special   Meeting  in  person.
                                   However, to ensure your representation at the
                                   Special  Meeting,   you  are  urged  to  vote
                                   promptly   by  signing  and   returning   the
                                   enclosed  Proxy card. IF YOUR SHARES ARE HELD
                                   IN  STREET  NAME,  YOU  MUST  OBTAIN A PROXY,
                                   EXECUTED  IN YOUR  FAVOR,  FROM THE HOLDER OF
                                   RECORD  IN  ORDER  TO BE  ABLE TO VOTE AT THE
                                   SPECIAL MEETING.

Woodland Hills, California              Ronda Ferguson
________________, 2004                  CHIEF FINANCIAL OFFICER


IN ORDER TO ENSURE YOUR REPRESENTATION AT THE SPECIAL MEETING,  PLEASE COMPLETE,
DATE,  SIGN AND  RETURN  THE  ACCOMPANYING  PROXY IN THE  ENCLOSED  ENVELOPE  AS
PROMPTLY AS  POSSIBLE.  IF YOU RECEIVE  MORE THAN ONE PROXY CARD BECAUSE YOU OWN
SHARES REGISTERED IN DIFFERENT NAMES OR AT DIFFERENT ADDRESSES, EACH CARD SHOULD
BE COMPLETED AND RETURNED.





                                                            TAG-IT PACIFIC, INC.
                                              21900 BURBANK BOULEVARD, SUITE 270
                                                WOODLAND HILLS, CALIFORNIA 91367
                                                                  (818) 444-4100

PROXY STATEMENT
- --------------------------------------------------------------------------------


         These Proxy materials are delivered in connection with the solicitation
by the Board of  Directors  of Tag-It  Pacific,  Inc.,  a  Delaware  corporation
("Tag-It,"  the  "Company",  "we", or "us"),  of Proxies to be voted at our 2004
Special Meeting of stockholders and at any adjournments or postponements.

         You are  invited  to attend our  Special  Meeting  of  stockholders  on
February 11, 2004,  beginning at 10:00 a.m.  Pacific  Time.  The meeting will be
held at the Company's corporate  headquarters at 21900 Burbank Boulevard,  Suite
270, Woodland Hills, California 91367.

STOCKHOLDERS ENTITLED TO VOTE.

         Holders of Tag-It  common  stock and  convertible  redeemable  series C
preferred  stock at the close of  business  on January 5, 2004 are  entitled  to
receive  this  notice and to vote their  shares at the  Special  Meeting.  As of
January 5, 2004, there were  _____________  shares of common stock  outstanding.
Holders of our convertible redeemable series C preferred stock have the right to
vote with our common stock based on the number of common  shares that the series
C preferred  shares could be converted into on the record date. As of January 5,
2004, the outstanding shares of convertible  redeemable series C preferred stock
were convertible into 607,288 shares of common stock,  which shares are entitled
to vote with our common stock.

MAILING OF PROXY STATEMENTS.

         We anticipate  mailing this Proxy Statement and the accompanying  Proxy
to stockholders on or about January 16, 2004.

PROXIES.

         Your vote is important. If your shares are registered in your name, you
are a share  owner of record.  If your  shares are in the name of your broker or
bank,  your shares are held in street name. We encourage you to vote by Proxy so
that your shares will be represented and voted at the meeting even if you cannot
attend.  All share owners can vote by written Proxy card.  Your  submitting  the
enclosed  Proxy will not limit your right to vote at the Special  Meeting if you
later decide to attend in person.  IF YOUR SHARES ARE HELD IN STREET  NAME,  YOU
MUST OBTAIN A PROXY,  EXECUTED IN YOUR FAVOR, FROM THE HOLDER OF RECORD IN ORDER
TO BE ABLE TO VOTE AT THE MEETING.  If you are a share owner of record,  you may
revoke  your Proxy at any time  before  the  meeting  either by filing  with the
Secretary of the Company,  at its principal  executive offices, a written notice
of revocation or a duly executed Proxy bearing a later date, or by attending the
Special  Meeting  and  expressing  a desire to vote your  shares in person.  All
shares entitled to vote and represented by properly  executed  Proxies  received
prior to the  Special  Meeting,  and not  revoked,  will be voted at the Special
Meeting in accordance with the  instructions  indicated on those Proxies.  If no
instructions are indicated on a properly executed Proxy, the shares  represented
by that Proxy will be voted as recommended by the Board of Directors.

QUORUM.

         The  presence,  in  person  or by  Proxy,  of a  majority  of the votes
entitled to be cast by the stockholders  entitled to vote at the Special Meeting
is necessary to constitute a quorum.  Abstentions  and broker  non-votes will be
included in the number of shares present at the Special  Meeting for determining
the presence of a quorum.  Broker non-votes occur when a broker holding customer
securities in street name has not received voting instructions from the customer
on certain  non-routine  matters and,  therefore,  is barred by the rules of the
applicable securities exchange from exercising  discretionary  authority to vote
those securities.


                                       1



VOTING.

         Each  share of  Tag-It  common  stock is  entitled  to one vote on each
matter  properly  brought  before  the  meeting.  In  addition,  each  share  of
convertible redeemable series C preferred stock is entitled to one vote for each
share of common  stock  into which it is  convertible  on each  matter  properly
brought before the meeting.

APPROVAL  OF  ISSUANCE  OF COMMON  STOCK UPON  CONVERSION  OF SERIES D PREFERRED
STOCK.

         The approval of the  issuance of up to  5,728,180  shares of our common
stock issuable upon conversion of our  outstanding  shares of Series D Preferred
Stock will  require the  affirmative  vote of a majority of the shares of common
stock present or represented  and entitled to vote at the Special  Meeting.  For
purposes of the vote to approve the issuance of common stock upon  conversion of
the Series D Preferred Stock,  abstentions will be counted toward the tabulation
of votes cast on the proposal  and will have the same effect as negative  votes,
while  broker  non-votes  will not be counted as votes cast for or against  such
matters.

VOTING AGREEMENTS.

     Sanders Morris Harris Inc.,  which acted as placement agent for the Company
with respect to the sale of the shares of Series D Preferred  Stock, has entered
into voting  agreements  with certain  stockholders  of the  Company,  including
members of management,  holding  approximately 51% of the Company's  outstanding
voting securities (the "Voting Agreements"), pursuant to which such stockholders
have agreed to vote all shares subject to the Voting  Agreements in favor of the
proposal to approve  issuance of shares of our common stock upon  conversion  of
the preferred stock.  Concurrently with the execution of the Voting  Agreements,
each such  stockholder  also  delivered to Sanders  Morris Harris an irrevocable
proxy appointing Sanders Morris Harris as proxy to vote the shares in accordance
with the Voting Agreements.

OTHER MATTERS.

         At the date this Proxy  Statement went to press,  we do not know of any
other matter to be raised at the Special Meeting. However, if any other business
shall properly come before the Special Meeting or any adjournment  thereof,  the
persons  named as proxies will have  discretionary  authority to vote the shares
represented by the accompanying proxy in accordance with their best judgment.


                                       2



ITEM 1:  APPROVAL  OF  ISSUANCE  OF  COMMON  STOCK UPON  CONVERSION  OF SERIES D
         PREFERRED STOCK
- --------------------------------------------------------------------------------


         Item 1 is the approval of the issuance of up to 5,728,180 shares of our
common stock upon  conversion  of our  outstanding  shares of Series D Preferred
Stock.  The Board of Directors  has  approved,  contingent  upon approval by the
Company's  stockholders at the Special Meeting,  the issuance of up to 5,728,180
shares of our common stock (the "Series D Conversion Shares") upon conversion of
the  Company's  outstanding  shares of Series D  Preferred  Stock.  The Board of
Directors  is  submitting  the  proposal to approve the issuance of the Series D
Conversion Shares to the stockholders for approval at the Special Meeting.

         The Series D Conversion Shares,  when issued,  would become part of the
existing  class of common stock and would have the same rights and privileges as
the shares of common stock now issued and  outstanding.  There are no preemptive
rights  relating  to the common  stock.  As of  December  15,  2004,  there were
11,513,409  shares of our common stock issued and  outstanding.  If issued,  the
Series D Conversion  Shares would represent  approximately 33% of our issued and
outstanding  shares of common stock.  Our common stock is listed on the American
Stock  Exchange.  The  continued  listing  requirements  of the  American  Stock
Exchange  prohibit  us from  issuing  shares  of  common  stock in a  non-public
offering prior to obtaining  stockholder  approval if the price per share of the
securities  in the  offering  is less than the  greater  of book value or market
value of our common stock and the proposed issuance would result in the issuance
of 20% or more of the common  stock or voting  power of the  Company  before the
issuance. Assuming immediate conversion of all of the shares of Preferred Stock,
the total  number of Series D  Conversion  Shares  would be in excess of the 20%
threshold. Therefore, we may not issue the Series D Conversion Shares unless and
until the issuance has been approved by our stockholders.

PRIVATE PLACEMENT OF SERIES D PREFERRED STOCK.

         In December 2003, we entered into Subscription  Agreements with certain
investors  pursuant to which we sold 572,818 shares of Series D Preferred  Stock
(the "Preferred  Shares") at a price of $44.00 per share in a private  placement
transaction.   We  received  proceeds  of  approximately   $23,200,000  in  this
transaction,  after payment of placement agent fees and other offering expenses.
We  intend to use the  proceeds  for  repayment  of debt and  general  corporate
purposes.

         Sanders Morris Harris Inc. acted as placement  agent in connection with
the December 2003 private placement financing  transaction.  For its services as
placement  agent, we paid Sanders Morris Harris a fee equal to 7.5% of our gross
proceeds  from the  financing  ($1,890,299).  We also  paid  for the  reasonable
out-of-pocket  expenses  incurred by Sanders  Morris Harris and all investors in
the amount of $45,000. In addition, we issued to Sanders Morris Harris a warrant
to purchase 572,818 shares of our common stock at an exercise price of $4.74 per
share.  The  warrants  have a term of 5 years.  The  warrants  vest  and  become
exercisable in full on June 18, 2004.

         We entered into a registration  rights agreement with the purchasers of
the Preferred Shares. Pursuant to this registrant rights agreement, we agreed to
file a  registration  statement  on  Form  S-3  registering  the  resale  by the
investors  of the  Series  D  Conversion  Shares  and to keep  the  registration
statement  effective  until  the  later of one year or  until  all the  Series D
Conversion Shares held by the investors may be sold by them pursuant to Rule 144
promulgated under the Securities Act of 1933. This registration rights agreement
also  provides  that if we do not  register  for resale the Series D  Conversion
Shares  within 60 days of the  closing  date (or 150 days in the event of a full
review of the registration statement by the Securities and Exchange Commission),
then we must pay each of the investors 1% of the per share  purchase  price paid
by such investor for each Preferred  Share  purchased for each month  thereafter
that we do not register the shares.  The  expenses of such  registration,  other
than selling expenses (including  broker's fees and commissions),  will be borne
by us.

REASONS FOR THE PRIVATE PLACEMENT.

         The  proceeds  of the  private  placement  financing  transaction  will
strengthen our working capital and will support the integration and expansion of
our  operations  to  exploit  our  rights  under  our TALON  trade  name and the
expansion of our  operations  in the Asian and Caribbean  markets.  This private
placement  will also assist us in further  developing  our waistband  technology
under our TEKFIT division. We believe the private placement financing will allow
us to maximize growth  opportunities that would otherwise be left in incubation.
We also want


                                       3



to  continue  building  and  improving  our  processes  in order to  exceed  the
expectations of our new and existing customers.

TERMS OF SERIES D PREFERRED STOCK.

         Except as required by law, the Preferred  Shares have no voting rights.
The Preferred Shares accrue dividends,  commencing on June 1, 2004, at an annual
rate of 5% of the initial stated value of $44.00 per share,  payable  quarterly.
In the event of a  liquidation,  dissolution  or winding-up of the Company,  the
Preferred  Shares will be entitled to receive,  prior to any distribution on the
common stock, a distribution  equal to the initial stated value of the Preferred
Shares plus all accrued and unpaid dividends.

         If the  stockholders  approve the  issuance of the Series D  Conversion
Shares,  each Preferred Share will be automatically  converted into 10 shares of
our common  stock (as  adjusted  for stock  dividends,  combinations,  splits or
similar  events),  for an aggregate of 5,728,180  shares of common stock. If the
stockholders do not approve the issuance of the conversion shares at the Special
Meeting, the Preferred Shares will not be convertible into common stock.

CERTAIN EFFECTS OF THE PROPOSAL.

         The Board of  Directors  believes  that the approval of the issuance of
the Series D Conversion  Shares is in the best  interests of the Company and the
stockholders.  However,  the following  should be considered by a stockholder in
deciding how to vote upon the proposal.

         DILUTION. If the issuance of the Series D Conversion Shares is approved
by the stockholders at the Special Meeting,  the holders of the Preferred Shares
would automatically have each Preferred Share converted into 10 shares of common
stock,  or an aggregate of 5,728,180  shares of common stock.  When issued,  the
Series D Conversion  Shares would represent  approximately  33% of the Company's
outstanding  shares of common  stock,  based upon the  11,513,409  shares of our
common  stock  outstanding  as of  December  15,  2003.  As a result,  following
conversion  of the  Preferred  Shares and  issuance  of the Series D  Conversion
Shares, our stockholders would experience substantial dilution in the percentage
of Company equity they own.

         EFFECT OF ISSUANCE OF SERIES D CONVERSION  SHARES  BELOW MARKET  PRICE.
The  effective  issuance  price of the Series D  Conversion  Shares is $4.40 per
share.  The issuance of the Series D Conversion  Shares could depress the market
price of, and reduce  trading  activity in, our common stock by  increasing  the
number of shares  outstanding.  Such downward  pressure on our stock price could
encourage short sales by certain  investors that could place further pressure on
the price of our common stock.

         PRINCIPAL  EFFECTS OF  NON-APPROVAL.  If the  issuance  of the Series D
Conversion Shares is not approved,  the Preferred Shares will not be convertible
into common  stock.  Commencing  on June 1, 2004,  the holders of the  Preferred
Shares will be entitled to receive a dividend at an annual rate of 5%. We cannot
pay a dividend on our common stock unless all accrued dividends on the Preferred
Shares  have been paid in full.  Additionally,  in the event of a  voluntary  or
involuntary  liquidation,  dissolution or winding up of the Company, the holders
of the  Preferred  Shares  will be entitled  to receive  $44.00 per share,  plus
accrued and unpaid dividends before any distributions are made to the holders of
our common stock.


                                       4



BOARD RECOMMENDATION AND VOTE.

         The  approval of the  issuance of the Series D  Conversion  Shares will
require the affirmative  vote of a majority of the shares present or represented
and  entitled to vote at the Special  Meeting.  The Board of Directors is of the
opinion  that the  issuance  of the  Series D  Conversion  Shares is in the best
interests of the Company and  recommends a vote for the approval of the issuance
of the Series D  Conversion  Shares.  All  Proxies  will be voted to approve the
issuance of the Series D Conversion  Shares  unless a contrary vote is indicated
on the enclosed Proxy card.

         THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE "FOR" THE APPROVAL
OF ISSUANCE OF UP TO  5,728,180  SHARES OF COMMON STOCK UPON  CONVERSION  OF THE
SERIES D PREFERRED STOCK.


                                       5



                             PRINCIPAL STOCKHOLDERS

         The following  table  presents  information  regarding  the  beneficial
ownership of our common stock as of January 5, 2004:

         o        each person who is known to us to be the  beneficial  owner of
                  more than 5.0% of our outstanding common stock;
         o        each of our directors;
         o        the Named Executive Officers; and
         o        all of our directors and executive officers as a group

         Beneficial  ownership is determined in accordance with the rules of the
Securities and Exchange  Commission that deem shares to be beneficially owned by
any person who has or shares  voting or  investment  power with  respect to such
shares.  Shares of common stock under warrants or options currently  exercisable
or  exercisable  within  60 days of the  date of  this  information  are  deemed
outstanding  for purposes of computing  the  percentage  ownership of the person
holding such  warrants or options but are not deemed  outstanding  for computing
the  percentage  ownership of any other person.  As a result,  the percentage of
outstanding  shares of any person as shown in this  table  does not  necessarily
reflect the person's actual ownership or voting power with respect to the number
of shares of common  stock  actually  outstanding  at January  5,  2004.  Unless
otherwise  indicated,  the persons named in this table have sole voting and sole
investment power with respect to all shares shown as beneficially owned, subject
to community property laws where applicable.

         The  address of each  person  listed is in our care,  at 21900  Burbank
Boulevard,  Suite 270, Woodland Hills,  California  91367,  unless otherwise set
forth below such person's name.

                                                           NUMBER OF    PERCENT
NAME OF BENEFICIAL OWNER                                    SHARES      OF CLASS
- ----------------------------------------------------       ---------    --------

DIRECTORS:
Colin Dyne (1) .....................................       1,792,580      14.9%
Mark Dyne (2) ......................................       1,090,512       9.1%
Kevin Bermeister (3) ...............................         222,217       1.9%
Jonathan Burstein (4) ..............................         262,038       2.2%
Brent Cohen (5) ....................................          70,000      *
Michael Katz (6) ...................................          50,000      *

NON-DIRECTOR NAMED EXECUTIVE OFFICERS:
Jonathan Markiles (7) ..............................         133,248       1.1%
Ronda Ferguson (8) .................................         108,750      *

5% HOLDERS:
Gerard Guez
3151 East Washington Blvd
Los Angeles, CA  90023 .............................       1,005,000       8.7%

Todd Kay
3151 East Washington Blvd
Los Angeles, CA  90023 .............................       1,005,000       8.7%

Harris Toibb
307 21st Street
Santa Monica, CA  90402 (9) ........................       1,290,498      10.9%

The Estate of Harold Dyne (10) .....................         707,507       6.1%


                                       6



                                                           NUMBER OF    PERCENT
NAME OF BENEFICIAL OWNER                                    SHARES      OF CLASS
- ----------------------------------------------------       ---------    --------

Coats North America Consolidated, Inc.
Two Lake Point Plaza
4135 South Stream Blvd
Charlotte, NC  28217 (11) ..........................         607,288       5.0%

Directors and executive officers as a
  group (8 persons) (12) ...........................       3,729,245      28.5%
- ----------

* Less than one percent.
(1)  Includes 535,000 shares of common stock reserved for issuance upon exercise
     of stock options which currently are exercisable,  350,000 shares of common
     stock owned by Commerce  Investment Group, LLC and 250,000 shares of common
     stock held by a trust,  all of which are voted by Colin Dyne  pursuant to a
     voting agreement.
(2)  Includes 268,000 shares of common stock reserved for issuance upon exercise
     of stock options which currently are  exercisable,  83,334 shares of common
     stock reserved for issuance upon exercise of warrants  which  currently are
     exercisable  and 111,111  shares of common stock reserved for issuance upon
     conversion of debt which is currently convertible.
(3)  Includes  65,000 shares of common stock reserved for issuance upon exercise
     of stock options  which  currently are  exercisable.
(4)  Includes 166,250 shares of common stock reserved for issuance upon exercise
     of stock options which currently are exercisable.
(5)  Consists  of 70,000  shares of common  stock  reserved  for  issuance  upon
     exercise of stock options which currently are exercisable.
(6)  Consists  of 50,000  shares of common  stock  reserved  for  issuance  upon
     exercise of stock options which currently are exercisable.
(7)  Includes  80,000 shares of common stock reserved for issuance upon exercise
     of stock  options  which  currently  are  exercisable  and 39,235 shares of
     common  stock  reserved  for  issuance  upon  exercise  of  warrants  which
     currently are exercisable.
(8)  Consists of 108,750  shares of common  stock  reserved  for  issuance  upon
     exercise of stock options which are currently exercisable.
(9)  Includes 333,332 shares of common stock reserved for issuance upon exercise
     of warrants which are currently exercisable.
(10) Harold Dyne served as our President  until his death in October  1999.  The
     estate of Mr. Dyne  exercises  beneficial  ownership  over shares  which he
     previously  held. The shares consist of 659,507 shares of common stock held
     by H&A Dyne  Holdings,  LP and 48,000  shares of common stock  reserved for
     issuance upon exercise of stock options which currently are exercisable.
(11) Consists of 759,494  shares of series C  convertible  redeemable  preferred
     stock,  convertible  into 607,288  shares of common  stock.  The shares are
     convertible at the election of the holder after  September 20, 2003 and are
     entitled to vote with our common stock based on the number of common shares
     that the series C preferred  shares could be  converted  into on the record
     date.
(12) Includes  1,343,000  shares of common  stock  reserved  for  issuance  upon
     exercise of stock options which currently are  exercisable,  350,000 shares
     of common stock owned by Commerce  Investment Group, LLC and 250,000 shares
     of common  stock  held by a trust,  all of which  are  voted by Colin  Dyne
     pursuant to a voting agreement, 111,111 shares of common stock reserved for
     issuance upon conversion of debt which is currently convertible and 122,569
     shares of common  stock  reserved for  issuance  upon  exercise of warrants
     which currently are exercisable.

         The information as to shares  beneficially  owned has been individually
furnished by the  respective  directors,  named  executive  officers,  and other
stockholders  of the company,  or taken from documents filed with the Securities
and Exchange Commission.


                                       7



                              STOCKHOLDER PROPOSALS

         Any  stockholder  who  intends to present a proposal at the 2004 Annual
Meeting of stockholders for inclusion in the Company's Proxy Statement and Proxy
form relating to such Annual Meeting must submit such proposal to the Company at
its principal executive offices by February 14, 2004. In addition,  in the event
a  stockholder  proposal is not received by the Company by April 16,  2004,  the
Proxy to be solicited by the Board of Directors for the 2004 Annual Meeting will
confer discretionary authority on the holders of the Proxy to vote the shares if
the proposal is presented at the 2004 Annual  Meeting  without any discussion of
the proposal in the Proxy Statement for such meeting.

         SEC rules and  regulations  provide  that if the date of the  Company's
2004 Annual  Meeting is  advanced or delayed  more than 30 days from the date of
the 2003 Annual Meeting,  stockholder  proposals  intended to be included in the
proxy  materials  for the 2004  Annual  Meeting  must be received by the Company
within a reasonable  time before the Company  begins to print and mail the proxy
materials for the 2004 Annual Meeting.  Upon  determination  by the Company that
the date of the 2004 Annual  Meeting will be advanced or delayed by more than 30
days from the date of the 2003 Annual  Meeting,  the Company will  disclose such
change in the earliest possible Quarterly Report on Form 10-Q.

                             SOLICITATION OF PROXIES

         It is expected that the  solicitation  of Proxies will be by mail.  The
cost of  solicitation  by management  will be borne by the Company.  The Company
will reimburse brokerage firms and other persons representing  beneficial owners
of shares for their reasonable disbursements in forwarding solicitation material
to such  beneficial  owners.  Proxies  may also be  solicited  by certain of the
Company's directors and officers, without additional compensation, personally or
by mail, telephone, telegram or otherwise.

                           ANNUAL REPORT ON FORM 10-K

         THE COMPANY'S ANNUAL REPORT ON FORM 10-K, WHICH HAS BEEN FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION FOR THE YEAR ENDED DECEMBER 31, 2002, WILL BE
MADE  AVAILABLE TO  STOCKHOLDERS  WITHOUT  CHARGE UPON WRITTEN  REQUEST TO RONDA
FERGUSON,   CHIEF  FINANCIAL  OFFICER,   TAG-IT  PACIFIC,  INC.,  21900  BURBANK
BOULEVARD, SUITE 270, WOODLAND HILLS, CALIFORNIA 91367.

                                             ON BEHALF OF THE BOARD OF DIRECTORS

                                             Ronda Ferguson
                                             Chief Financial Officer

Tag-It Pacific, Inc.,
21900 Burbank Boulevard, Suite 270,
Woodland Hills, California 91367

____________, 2004


                                       8



                              TAG-IT PACIFIC, INC.
                    PROXY FOR SPECIAL MEETING OF STOCKHOLDERS

           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned,  a stockholder of Tag-It Pacific,  Inc., a Delaware corporation
(the "Company"), hereby nominates, constitutes and appoints Colin Dyne and Ronda
Ferguson,  or either one of them,  as proxy of the  undersigned,  each with full
power  of  substitution,  to  attend,  vote and act for the  undersigned  at the
Special Meeting of Stockholders of the Company, to be held on February 11, 2004,
and any postponements or adjournments thereof, and in connection  therewith,  to
vote and represent all of the shares of the Company which the undersigned  would
be entitled to vote with the same effect as if the undersigned were present,  as
follows:

A VOTE FOR THE PROPOSAL IS RECOMMENDED BY THE BOARD OF DIRECTORS:

Proposal 1.  To  approve  the  issuance  of  up to  5,728,180  shares of  common
             stock issuable upon conversion of the outstanding  shares of Series
             D Preferred Stock.

     |_| FOR                      |_| AGAINST                   |_| ABSTAIN

The undersigned  hereby revokes any other proxy to vote at the Special  Meeting,
and hereby  ratifies and confirms all that said attorneys and proxies,  and each
of them, may lawfully do by virtue hereof.  With respect to matters not known at
the time of the  solicitation  hereof,  said proxies are  authorized  to vote in
accordance with their best judgment.

THIS PROXY WILL BE VOTED IN ACCORDANCE WITH THE INSTRUCTIONS SET FORTH ABOVE OR,
TO THE EXTENT NO CONTRARY DIRECTION IS INDICATED,  WILL BE TREATED AS A GRANT OF
AUTHORITY TO VOTE FOR ALL  PROPOSALS.  IF ANY OTHER BUSINESS IS PRESENTED AT THE
SPECIAL  MEETING,  THIS  PROXY  CONFERS  AUTHORITY  TO AND  SHALL  BE  VOTED  IN
ACCORDANCE WITH THE RECOMMENDATIONS OF THE PROXIES.

The undersigned  acknowledges receipt of a copy of the Notice of Special Meeting
dated January ____, 2004 and the  accompanying  Proxy Statement  relating to the
Special Meeting.

                                                  Dated:__________________, 2004

                                                  Signature:____________________

                                                  Signature:____________________
                                                  Signature(s) of Stockholder(s)
                                                    (See Instructions Below)

                                                  The Signature(s) hereon should
                                                  correspond  exactly  with  the
                                                  name(s) of the  Stockholder(s)
                                                  appearing    on   the    Share
                                                  Certificate.  If stock is held
                                                  jointly,   all  joint   owners
                                                  should  sign.  When signing as
                                                  attorney,            executor,
                                                  administrator,    trustee   or
                                                  guardian,   please  give  full
                                                  title as such.  If signer is a
                                                  corporation,  please  sign the
                                                  full  corporation   name,  and
                                                  give title of signing officer.

|_|      Please  indicate by checking this box if you  anticipate  attending the
         Special Meeting.

                PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD
                      PROMPTLY USING THE ENCLOSED ENVELOPE